Emergent Medical Partners is a California-based life sciences venture capital firm focused on early-stage medical device and healthcare companies. Founded by Dr. Thomas Fogarty, the firm provides funding and expertise across the financial, medical, and engineering facets of medical device development.
33% of their portfolio is in Healthcare. Average disclosed round size is $40.2M (across 16 rounds with reported amounts).
Portfolio
13
Fund Size
—
Top Stage
Series B
Last 12 Mo
0
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
18 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Heartflow | Growth | $215M | Jan 2023 |
| SStandard Bariatrics, Inc. | Series B | $35M | Jun 2021 |
 Relievant MedSystems | Series D | $70M | Oct 2020 |
 ReThink Medical | Series A | $3M | May 2017 |
| CChrono Therapeutics | Series B | $47.6M | Sep 2016 |
| CChrono Therapeutics | Seed | $47.6M | Jan 2016 |
 Focal Therapeutics | Series C | $3.8M | Aug 2014 |
 Crux Biomedical | Unknown | $12M | Jan 2011 |
| CCianna Medical | Unknown | $10M | Jan 2009 |
| CCianna Medical | Series B | $8M | Jan 2008 |
| CCyberHeart | Series A | $9M | Jan 2008 |
 Arterys | Series C | $28M | — |
 Fractyl Health | Series E | — | — |
| SStandard Bariatrics, Inc. | Series B | $35M | — |
| SStandard Bariatrics, Inc. | Series A | — | — |
 Fractyl | Series E | $55M | — |
 EBR Systems | Unknown | $20M | — |
| Fractyl | Series D | $44M | — |
Top Co-Investors
RiverVest Venture Partners3 shared
U.S. Venture Partners3 shared
Canaan Partners3 shared
Endeavour Vision3 shared
Domain Associates3 shared
Mithril Capital Management3 shared
GV3 shared
General Catalyst3 shared
True Ventures3 shared
Asahi Kasei2 shared
Fountain Healthcare Partners2 shared
Cota Capital2 shared
Kaiser Permanente Ventures2 shared
Mayo Clinic Ventures2 shared
Catalio Capital Management2 shared
CDIB Capital Group2 shared
Bessemer Venture Partners2 shared
LAUNCH1 shared
QCA Ventures1 shared
Last updated: 20 October 2026